← All tickers

Is FATE Worth Buying in 2026?

Fate Therapeutics, Inc.

STOCK BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Updated 2026-08-16

Here’s whether Fate Therapeutics, Inc. (FATE) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+2.10% over 10 days); RSI 56 — healthy momentum range; strong 1-year return of +140.2%; 3-month momentum positive (+46.4%). Currently 20.4% off its 52-week high. Score: +7/7.

Ready to act on this? 📈 Trade on Webull

FATE is in a confirmed uptrend, trading above both its 50-day ($2.49) and 200-day ($1.62) moving averages. An RSI of 55.6 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +140.2% compares to +20.4% for SPY (beat the market by 119.8%). The current 20.4% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $24,019 today
vs. S&P 500 (SPY) — same period beat market by 119.8%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

✓Above 200-day MA ($1.62)
✓Above 50-day MA ($2.49)
✓RSI(14) neutral zone (30–70) — currently 55.6
✓Positive return (+140.2%)
!Within 10% of period high (−20.4%)
Period Range $2.57
$0.93 $3.23
RSI (14) 55.6
0 · OversoldOverbought · 100

Key Metrics

Price$2.57
Period Return+140.2%
Period High$3.23
Period Low$0.93
Drawdown−20.4%
MA-50$2.49
MA-200$1.62
RSI (14)55.6
Avg Volume (30d)2.5M
vs. SPYbeat by 119.8%
Return Rank#101 of 1252

Trade FATE

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers